20/20 Biolabs Common Stock Net Income

As of the most recent data (June 2026), AIDX shows a net income of $-6.9M. That is below the sector sector average of $89M. Scroll down for historical charts and peer comparison views.

The its sector sector average net income is about $89M. 20/20 Biolabs Common Stock is at $-6.9M, which is lower that average. That is roughly 107.8% below the sector mean. Use the comparison chart on this page to see how AIDX stacks up against individual peers as well.

Tracking AIDX's net income over time shows whether 20/20 Biolabs Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $-6.9M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net income page, Stockcircle has 20/20 Biolabs Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net income (currently $-6.9M) with ownership activity and broader fundamentals.